Table 1 Baseline characteristics.

From: Can non-pharmacological comfort care replace fentanyl in LISA? The NONA-LISA feasibility study

 

Fentanyl (N = 8)

Saline (N = 9)

Total (N = 17)

Demographic characteristics

 Gestational age, weeks’ PMA, median [IQR]

29 [26–29]

28 [27–28]

28 [26–29]

 Birth weight, g, median [IQR]

956 [838–1052]

950 [826–1055]

950 [826–1055]

Sex, n (%)

 Male

5 (63)

8 (89)

13 (77)

 Female

3 (38)

1 (11)

4 (24)

 Multiple birth, n (%)

3 (38)

3 (33)

6 (35)

Peripartum characteristics

 Exposure to antenatal glucocorticoids, doses prior to delivery, n (%)

  2 or more

6 (75)

7 (78)

13 (77)

  1

2 (25)

1 (11)

3 (18)

  No

0 (0)

1 (11)

1 (6)

Delivery mode, n (%)

 Caesarean section

6 (75)

8 (89)

14 (82)

 Vaginal

2 (25)

1 (11)

3 (18)

 Apgar score at 5 min, median [IQR]

10 [10–10]

10 [8–10]

10 [9–10]

  1. Baseline characteristics stratified for saline or fentanyl as premedication for LISA and for the total population included in the NONA-LISA feasibility study.
  2. IQR interquartile range, NONA-LISA NON-pharmacological Approach to Less Invasive Surfactant Administration.